Search hospitals > Arizona > Phoenix
Phoenix Children's Hospital
Claim this profilePhoenix, Arizona 85016
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Brain Tumor
Conducts research for Acute Lymphoblastic Leukemia
517 reported clinical trials
46 medical researchers
Summary
Phoenix Children's Hospital is a medical facility located in Phoenix, Arizona. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Brain Tumor, Acute Lymphoblastic Leukemia and other specialties. Phoenix Children's Hospital is involved with conducting 517 clinical trials across 719 conditions. There are 46 research doctors associated with this hospital, such as Jessica Boklan, Alok K. Kothari, Lindsey Hoffman, and Stewart Goldman, MD.Area of expertise
1Leukemia
Global LeaderStage II
Philadelphia chromosome positive
BCR-ABL1 positive
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Jessica BoklanPhoenix Childrens Hospital7 years of reported clinical research
Expert in Leukemia
Expert in Tumors
31 reported clinical trials
78 drugs studied
Alok K. KothariPhoenix Childrens Hospital7 years of reported clinical research
Expert in Tumors
Studies Cancer
17 reported clinical trials
41 drugs studied
Lindsey HoffmanPhoenix Childrens Hospital4 years of reported clinical research
Expert in Brain Tumor
Studies Astrocytoma
14 reported clinical trials
25 drugs studied
Stewart Goldman, MDLurie Children's Hospital-Chicago8 years of reported clinical research
Studies Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
13 reported clinical trials
26 drugs studied
Clinical Trials running at Phoenix Children's Hospital
Brain Tumor
Germ Cell Tumors
Crohn's Disease
Osteosarcoma
Non-Hodgkin's Lymphoma
Neurofibromatosis
Tumors
Neuroblastoma
Rhabdomyosarcoma
Langerhans Cell Histiocytosis
Dabrafenib + Trametinib
for Brain Tumors
This trial is studying the effects of two cancer medications, dabrafenib and trametinib, in children. These drugs work by stopping signals that make cancer cells grow. Dabrafenib and trametinib have shown benefits in various BRAF-mutant tumors, including melanoma, lung cancer, and thyroid cancer. The goal is to see how these treatments affect children over time.
Recruiting3 awards Phase 47 criteria
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Phoenix Children's Hospital?
Phoenix Children's Hospital is a medical facility located in Phoenix, Arizona. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Brain Tumor, Acute Lymphoblastic Leukemia and other specialties. Phoenix Children's Hospital is involved with conducting 517 clinical trials across 719 conditions. There are 46 research doctors associated with this hospital, such as Jessica Boklan, Alok K. Kothari, Lindsey Hoffman, and Stewart Goldman, MD.
Where is Phoenix Children's Hospital located?
Phoenix Children's Hospital is located at 1919 E. Thomas Rd., Phoenix, AZ 85016.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at Phoenix Children's Hospital, contact the following departments:
- **Financial Counseling**: For general financial assistance, call 602-933-2000. Available Monday to Friday, 7 am to 6:30 pm MT, and Saturday to Sunday, 8 am to 4:30 pm MT.
- **Customer Service**: For billing inquiries, contact 602-933-8700. Open Monday to Friday, 8 am to 5 pm MT.
- **Financial Assistance Application**: Apply for financial assistance at the Financial Counselor Offices, the Customer Service Department, or through the Phoenix Children's website.
- **Charity, Low-Income & Uninsured Program**: For information, call 602-933-2000.
These departments help with eligibility for financial assistance, understanding billing, and exploring payment and coverage options.
What insurance does Phoenix Children's Hospital accept?
Phoenix Children's Hospital accepts a wide range of health insurance plans, including but not limited to Aetna Health, Inc., America's Choice Provider Network (ACPN), Arizona Complete Health, and Blue Cross Blue Shield of Arizona (BCBSAZ). For transplant procedures, accepted insurance includes Accarent Health, AHCCCS, BCBSAZ, and Cigna LifeSource among others. It is recommended to check with your insurance provider directly to confirm coverage and network status for specific services or procedures at Phoenix Children's Hospital.
What awards or recognition has Phoenix Children's Hospital received?
Phoenix Children's Hospital is renowned for its focus on pediatric malignancy and hematologic disorder research. It participates in over 70 clinical trials for patients with various types of cancers and blood disorders through its Center for Cancer and Blood Disorders. The hospital has achieved association accreditation for human research protection, underscoring its commitment to ethically sound research.